Thomas Ferkol, MD, was installed as president-elect of the American Thoracic Society during the ATS International Conference in May 2013. He will serve through May 2014 and he will serve as ATS president from 2014 to 2015.
Dr. Ferkol is professor of pediatrics, cell biology, and physiology and director of the multidisciplinary Division of Pediatric Allergy, Immunology, and Pulmonary Medicine at the Washington University School of Medicine. After earning his medical degree from the Ohio State University College of Medicine, he completed residency training at the University of North Carolina at Chapel Hill. He received his fellowship training in pediatric pulmonology at Case Western Reserve University and subsequently joined their pediatric faculty. He moved to Washington University in 2000, where he has directed the comprehensive Cystic Fibrosis Center for the past decade.
An American Lung Association Edward Livingston Trudeau Scholar and recipient of the Cystic Fibrosis Foundation (CFF) LeRoy Matthew’s Physician-Scientist Award, his research has focused on characterizing genetic and molecular factors that contribute to airway involvement in cystic fibrosis and primary ciliary dyskinesia. With support from the National Institutes of Health (NIH), CFF and March of Dimes, he and his collaborators have identified potential therapeutic targets for suppurative lung diseases and developed novel approaches for drug delivery. He is an investigator for the NIH-supported Genetic Diseases of Mucociliary Clearance Consortium, and has assembled clinical, biomedical and engineering research collaborative at Washington University, studying genetic andphenotypic spectrum of ciliopathies.
Dr. Ferkol also chairs the Finance Committee and serves as a non-voting member of the Council of Chapter Representatives and all committees except the Nominating Committee. Since joining the ATS in 1995, Dr. Ferkol has been active in the Assembly Pediatrics, having served as assembly chair and chair of its Nominating Committee. He has also served as a member on the ATS Finance Committee and the Membership Committee. He has been a member of several scientific review groups, including the NIH Gene and Drug Delivery Study Section, ATS Career Development Grants Review Committee, CFF Research Development Program Review Committee and CFF Functional Genomics Review Committee. Finally, he is a current member of the American Board of Pediatrics Subboard of Pediatric Pulmonology.